Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Predicts 11 Mil. Low-Income Seniors Will Enroll In Medicare Rx

Executive Summary

The Centers for Medicare & Medicaid Services predicts that 10.9 mil. Medicare beneficiaries eligible for low-income assistance will enroll during the first year of the new outpatient prescription drug benefit

You may also be interested in...



CMS Extends Medicare Rx Auto-Enrollment To Low-Income Beneficiaries

The Centers for Medicare & Medicaid Services will auto-enroll beneficiaries qualified for low-income subsidies in the drug benefit

CMS Extends Medicare Rx Auto-Enrollment To Low-Income Beneficiaries

The Centers for Medicare & Medicaid Services will auto-enroll beneficiaries qualified for low-income subsidies in the drug benefit

Medicare Outreach Crucial To Successful Drug Benefit, Kaiser Survey Shows

Medicare beneficiary education and outreach efforts over the next 15 months will be crucial in assuring significant uptake of the Part D drug benefit, a Kaiser Family Foundation/Harvard School of Public Health survey indicates

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel